These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17537170)

  • 21. Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy.
    Belcastro V; Costa C; Galletti F; Rossi A; Tambasco N; Striano P
    Epilepsy Behav; 2009 Jan; 14(1):269-70. PubMed ID: 18804185
    [No Abstract]   [Full Text] [Related]  

  • 22. A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy.
    Robins A; Patel M; Azim A
    J Am Geriatr Soc; 2012 Jan; 60(1):159-60. PubMed ID: 22239298
    [No Abstract]   [Full Text] [Related]  

  • 23. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare protein sequence variation in SV2A gene does not affect response to levetiracetam.
    Dibbens LM; Hodgson BL; Helbig KL; Oliver KL; Mulley JC; Berkovic SF; Scheffer IE
    Epilepsy Res; 2012 Sep; 101(3):277-9. PubMed ID: 22551666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meeting the challenge of treating epilepsy.
    Chadwick D; Wolf P
    Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335
    [No Abstract]   [Full Text] [Related]  

  • 26. The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production.
    Mintz M; Legoff D; Scornaienchi J; Brown M; Levin-Allen S; Mintz P; Smith C
    J Child Neurol; 2009 Jul; 24(7):807-15. PubMed ID: 19189934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors in patients with refractory epilepsy exposed to levetiracetam: a single-center study.
    Peltola J; Peltola M; Auvinen A; Keränen T; Liimatainen S; Kharazmi E; Fallah M
    Acta Neurol Scand; 2008 May; 117(5):332-6. PubMed ID: 18081915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ metabolism of levetiracetam in blood of patients with epilepsy.
    Patsalos PN; Ghattaura S; Ratnaraj N; Sander JW
    Epilepsia; 2006 Nov; 47(11):1818-21. PubMed ID: 17116020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
    Specchio N; Boero G; Michelucci R; Gambardella A; Giallonardo AT; Fattouch J; Di Bonaventura C; de Palo A; Ladogana M; Lamberti P; Vigevano F; La Neve A; Specchio LM
    Epilepsia; 2008 Apr; 49(4):663-9. PubMed ID: 18266754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus guidelines into the management of epilepsy in adults with an intellectual disability.
    Kerr M; ; Scheepers M; Arvio M; Beavis J; Brandt C; Brown S; Huber B; Iivanainen M; Louisse AC; Martin P; Marson AG; Prasher V; Singh BK; Veendrick M; Wallace RA
    J Intellect Disabil Res; 2009 Aug; 53(8):687-94. PubMed ID: 19527434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levetiracetam in focal epilepsy and hepatic porphyria: a case report.
    Paul F; Meencke HJ
    Epilepsia; 2004 May; 45(5):559-60. PubMed ID: 15101839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tolerability and efficacy of levetiracetam.
    Tellez-Zenteno JF
    Can J Neurol Sci; 2010 May; 37(3):309. PubMed ID: 20481263
    [No Abstract]   [Full Text] [Related]  

  • 33. Levetiracetam in the management of epilepsy.
    Leach JP
    Hosp Med; 2004 Dec; 65(12):740-4. PubMed ID: 15624450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effectiveness of levetiracetam in a patient with chronic motor tics, Rolandic epilepsy and attentional and behavioural disorder].
    Fernández-Mayoralas DM; Fernández-Jaén A; Muñoz-Jareño N; Calleja-Pérez B; Arroyo-González R
    Rev Neurol; 2009 Nov 1-15; 49(9):502-3. PubMed ID: 19859894
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE.
    Siniscalchi A; Mancuso F; Gallelli L; Ferreri GI; Giovambattista DS
    Ann Pharmacother; 2005; 39(7-8):1367. PubMed ID: 15956229
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.
    Hirsch LJ; Arif H; Buchsbaum R; Weintraub D; Lee J; Chang JT; Resor SR; Bazil CW
    Epilepsia; 2007 Jul; 48(7):1351-9. PubMed ID: 17573925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Levetiracetam (keppra) in epileptology].
    Kalinin VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):74-7. PubMed ID: 18683359
    [No Abstract]   [Full Text] [Related]  

  • 39. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S; Holt P; Benatar M
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.